354657.fig.001
Figure 1: Changes in the peak aspartate aminotransferase (AST) and alanine aminotransferase (ALT) levels following the switch from gefitinib to erlotinib treatment. The levels of both aminotransferases decreased after the change in EGFR-TKIs treatment.